📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The Na+K+-ATPase Inhibitor Marinobufagenin and Early Cardiovascular Risk in Humans: a Review of Recent Evidence. (2019)

First Author: Strauss M

Attributed to: The African Prospective study on the Early Detection and Identification of Cardiovascular disease and Hypertension (African-PREDICT) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s11906-019-0942-y

PubMed Identifier: 30980225

Publication URI: http://europepmc.org/abstract/MED/30980225

Type: Journal Article/Review

Volume: 21

Parent Publication: Current hypertension reports

Issue: 5

ISSN: 1522-6417